Yuji Watanabe
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 7
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 5
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Mycobacterium research and diagnosis 5
- Pneumonia and Respiratory Infections 4
- Small Animals top 10%
-
- Bacterial Identification and Susceptibility Testing 8
-
- Streptococcal Infections and Treatments 4
-
- Immune Response and Inflammation 4
- Co-authors
- Shōgo KuwaharaMasafumi SekiShuichi TawaraYoshimi WakaiKoji TomiyamaHiroko NakataHidenori SasaEisuke Nishio
- Journals
- SHILAP Revista de lepidopterología (3 papers)Biochemical and Biophysical Research Communications (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
In The Last Decade
Yuji Watanabe
41 papers receiving 511 citations
Peers
Comparison fields: 5 of 88
- Molecular Medicine 70
- Infectious Diseases 180
- Pharmacology 121
- Epidemiology 225
- Small Animals 42
Countries citing papers authored by Yuji Watanabe
This map shows the geographic impact of Yuji Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Watanabe more than expected).
Fields of papers citing papers by Yuji Watanabe
This network shows the impact of papers produced by Yuji Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Watanabe. The network helps show where Yuji Watanabe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuji Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | Pulmonary and Disseminated Mycobacterium avium Complex Cases Confirmed by Tissue-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay of Formalin-Fixed Paraffin-Embedded Tissues | 2022 | 1 |
| 7 | Sinobronchial Syndrome Patients with Suspected Non-Tuberculous Mycobacterium Infection Exacerbated by Exophiala dermatitidis Infection | 2022 | 6 |
| 8 | 2021 | 2 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 6 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 5 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 16 | |
| 15 | 2016 | 23 | |
| 16 | 1994 | 10 | |
| 17 | 1993 | 23 | |
| 18 | 1993 | 17 | |
| 19 | 1991 | 17 | |
| 20 | In vitro antibacterial activity of cefdinir, a new orally active cephalosporin | 1989 | 4 |
About Yuji Watanabe
Yuji Watanabe is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 44 papers that have together received 529 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antibiotic Resistance in Bacteria (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Mycobacterium research and diagnosis (5 papers), Streptococcal Infections and Treatments (4 papers), Pneumonia and Respiratory Infections (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Molecular Medicine (70 citations), Infectious Diseases (180 citations) and Pharmacology (121 citations). Yuji Watanabe has collaborated with scholars based in Japan, Belgium and France. Frequent co-authors include Shōgo Kuwahara, Masafumi Seki, Shuichi Tawara, Yoshimi Wakai, Koji Tomiyama, Hiroko Nakata, Hidenori Sasa, Eisuke Nishio, Shinya Arimura and Satoru Matsumoto. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.